High-Dose Intravenous Steroid Treatment Seems to Have No Long-Term Negative Effect on Bone Mineral Density of Young and Newly Diagnosed Multiple Sclerosis Patients: A Pilot Study

High-dose intravenous steroid treatment (HDIST) represents the first choice of treatment for multiple sclerosis (MS) relapses. Chronic oral glucocorticoid (GC) administration correlates with bone loss whereas data regarding HDIST in MS are still conflicting. Twenty-five newly diagnosed MS patients (...

Descripción completa

Detalles Bibliográficos
Autores principales: Simeakis, George, Anagnostouli, Maria, Fakas, Nikolaos, Koutsikos, John, Papatheodorou, Athanasios, Chanopoulos, Konstantinos, Athanasiou, Kwnstantinos, Papatheodorou, George, Zapanti, Evangelia, Alevizaki, Maria, Kaltsas, Gregory, Terpos, Evangelos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952957/
https://www.ncbi.nlm.nih.gov/pubmed/36831140
http://dx.doi.org/10.3390/biomedicines11020603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952957/
https://www.ncbi.nlm.nih.gov/pubmed/36831140
http://dx.doi.org/10.3390/biomedicines11020603

Ejemplares similares